Abstract:MicroRNAs (miRNAs) as a small RNA and post-transcriptional modulator are shown to have regulatory effects for different cellular activities and pathways, such as metabolism, virus replication and also cell growth. In addition, miRNAs can regulate the replication of the hepatitis B virus (HBV). Therefore, the expression profile of miRNAs was evaluated in HBV infected patient groups and healthy controls. The expression levels of following microRNAs (as noninvasive biomarkers) were compared in two experimental (t… Show more
“…The result of the survey of miRNA 141-5p expression in patients HBV like miR-NA 501-5p It is not diagnostic value (27). In the study like we found no significant difference between the six miRs (miR-199a-3p, miR-210, miR-205, miR155, miR-372, and miR-1) in the serum of patients infected with HBV compared to the control group (28). Our data indicated that mean ALT and AST were significantly higher (p<0.001) in the EPCH group than in ENCH and OHB and healthy controls, suggesting a positive correlation with hepatic necroinflammation.…”
MicroRNAs (miRNAs) as small RNA and post-transcriptional modulators are shown to have regulatory effects for different cellular activities and pathways, such as metabolism, virus replication and also cell growth. In addition, miRNAs can regulate the replication of the hepatitis B virus (HBV). Therefore, the expression profile of miRNAs was evaluated in HBV-infected patient groups and healthy controls. The expression levels of the following microRNAs (as noninvasive biomarkers) were compared in two experimental (those with various stages of HBV infection) and control groups to evaluate their diagnosis ability: mir141-5p and mir501-5p. RNA extraction was performed for 45 serum samples. The miRCURY LNA™ Universal RT-miRNA-PCR system and miRNA PCR panels were used for measuring microRNA expression profiles. To normalize quantitative values, the endogenous reference by UniSp6 expression was used. Serum mir141-5p and mir501-5 were significant None in patient in different stages of HBV infection(p<0.001) than in controls(p<0.01). Receiver operating characteristic (ROC) curve analyses suggested that serum has mir141-5p and mir501-5p none significant diagnostic value for HBV infection. Results suggest that mir141-5p and mir501-5 can not be used as diagnostic biomarkers for monitoring of HBV infection and other biomarkers in this disease need to be investigated.
“…The result of the survey of miRNA 141-5p expression in patients HBV like miR-NA 501-5p It is not diagnostic value (27). In the study like we found no significant difference between the six miRs (miR-199a-3p, miR-210, miR-205, miR155, miR-372, and miR-1) in the serum of patients infected with HBV compared to the control group (28). Our data indicated that mean ALT and AST were significantly higher (p<0.001) in the EPCH group than in ENCH and OHB and healthy controls, suggesting a positive correlation with hepatic necroinflammation.…”
MicroRNAs (miRNAs) as small RNA and post-transcriptional modulators are shown to have regulatory effects for different cellular activities and pathways, such as metabolism, virus replication and also cell growth. In addition, miRNAs can regulate the replication of the hepatitis B virus (HBV). Therefore, the expression profile of miRNAs was evaluated in HBV-infected patient groups and healthy controls. The expression levels of the following microRNAs (as noninvasive biomarkers) were compared in two experimental (those with various stages of HBV infection) and control groups to evaluate their diagnosis ability: mir141-5p and mir501-5p. RNA extraction was performed for 45 serum samples. The miRCURY LNA™ Universal RT-miRNA-PCR system and miRNA PCR panels were used for measuring microRNA expression profiles. To normalize quantitative values, the endogenous reference by UniSp6 expression was used. Serum mir141-5p and mir501-5 were significant None in patient in different stages of HBV infection(p<0.001) than in controls(p<0.01). Receiver operating characteristic (ROC) curve analyses suggested that serum has mir141-5p and mir501-5p none significant diagnostic value for HBV infection. Results suggest that mir141-5p and mir501-5 can not be used as diagnostic biomarkers for monitoring of HBV infection and other biomarkers in this disease need to be investigated.
“…As a result of the evolution of receptors for biological compounds over millions of years, scientists are currently designing hybrid devices using nanoscience and biology, known as Nano-biosensors so that they can detect molecules in extremely small concentrations, inaccessible regions, and even within cells [26] . Small RNAs (miRNAs) have been demonstrated to have regulatory effects on a variety of cellular processes and pathways, including metabolism, viral replication, and cell development [27] . Droplets of varying sizes are the primary means by which the COVID-19 infection spreads.…”
This century has introduced very deadly, dangerous, and infectious diseases to humankind such as the influenza virus, Ebola virus, Zika virus, and the most infectious SARS-CoV-2 commonly known as COVID-19 and have caused epidemics and pandemics across the globe. For some of these diseases, proper medications, and vaccinations are missing and the early detection of these viruses will be critical to saving the patients. And even the vaccines are available for COVID-19, the new variants of COVID-19 such as Delta, and Omicron are spreading at large. The available virus detection techniques take a long time, are costly, and complex and some of them generates false negative or false positive that might cost patients their lives. The biosensor technique is one of the best qualified to address this difficult challenge. In this systematic review, we have summarized recent advancements in biosensor-based detection of these pandemic viruses including COVID-19. Biosensors are emerging as efficient and economical analytical diagnostic instruments for early-stage illness detection. They are highly suitable for applications related to
“…The limited efficacy is primarily associated with the ability of HBV to evade innate immunity through various mechanisms (3)(4)(5)(6), including destroying the corresponding recognition receptors (7) and depleting the inflammatory factors important for the activation of adaptive immunity (8). Studies on HBV are becoming increasingly diverse, ranging from studies at the molecular and protein level, to studying the impact of the occurrence and development of viral hepatitis (9)(10)(11). However, to the best of our knowledge, only one study (12) has investigated the effects of transcription factors on the invasive activity of HBV in hepatocytes.…”
The mechanism of hepatitis B virus (HBV) immune tolerance remains unclear. our previous studies showed that aToH8 plays an important role in the liver tumor immune microenvironment; however, the specific immune regulatory mechanism requires further studies. Studies have shown that the hepatitis c virus (HcV) can cause hepatocyte pyroptosis; however, the relationship between HBV and pyroptosis is contested. Therefore, this study aimed to determine whether ATOH8 interfered with HBV activity through pyroptosis to further study the mechanism of ATOH8 on immune regulation and enrich our understanding of HBV-induced invasion. The expression levels of pyroptosis-related molecules (GSDMD and Caspase-1) in liver cancer tissues and peripheral blood mononuclear cells (PBMcs) of patients with HBV were assessed using qPCR and western blotting. HepG2.2.15 and Huh7 cells were used to overexpress ATOH8 using a recombinant lentiviral vector. The HBV dna expression levels in HepG2.2.15 cells were detected using absolute quantitative (q)PCR, and the hepatitis B surface antigen expression levels in the HepG2.2.15 cell culture supernatant were measured using ELISA. The expression of pyroptosis-related molecules in Huh7 and HepG2.2.15 cells was detected using western blotting and qPCR. Additionally, the expression levels of inflammatory factors including TNF-α, INF-α, IL-18, and IL-1β were detected using qPCR and ELISA. The liver cancer tissues and PBMcs of patients with HBV showed higher expressions of pyroptosis-related molecules than those of normal samples. ATOH8-overexpressed HepG2.2.15 cells had higher HBV expression levels but lower levels of pyroptosis-related molecules, such as GSDMD and Caspase-1, than those in the control group. Similarly, the expression levels of pyroptosis-related molecules in Huh7 cells overexpressing ATOH8 were lower than that in Huh7-GFP cells. Further detection of the expression of INF-α and TNF-α in HepG2.2.15 cells overexpressing ATOH8 showed that ATOH8 overexpression increased the expression of these inflammatory factors, including those associated with pyroptosis (IL-18 and IL-1β). in conclusion, aToH8 promoted HBV immune escape by inhibiting hepatocyte pyroptosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.